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Cytotoxic T lymphocytes are effector CD8+ T cells that eradicate infected and malignant
cells. Here we show that the transcription factor NFATc1 controls the cytotoxicity of mouse
cytotoxic T lymphocytes. Activation of Nfatc1−/− cytotoxic T lymphocytes showed a defective
cytoskeleton organization and recruitment of cytosolic organelles to immunological synapses.
These cells have reduced cytotoxicity against tumor cells, and mice with NFATc1-deﬁcient
T cells are defective in controlling Listeria infection. Transcriptome analysis shows diminished
RNA levels of numerous genes in Nfatc1−/− CD8+ T cells, including Tbx21, Gzmb and genes
encoding cytokines and chemokines, and genes controlling glycolysis. Nfatc1−/−, but not
Nfatc2−/− CD8+ T cells have an impaired metabolic switch to glycolysis, which can be
restored by IL-2. Genome-wide ChIP-seq shows that NFATc1 binds many genes that control
cytotoxic T lymphocyte activity. Together these data indicate that NFATc1 is an important
regulator of cytotoxic T lymphocyte effector functions.
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The primary function of CD8
+ T cells is to eradicate infected
and tumor cells. Upon activation and differentiation of
naïve CD8+ T cells to effector CD8+ T cells, cytotoxic T
lymphocytes (CTL) synthesize large amounts of the inﬂammatory
cytokines IFNγ and TNF, and the cytotoxic effector molecules
perforin and granzyme B, which are deposited in lytic granules in
the cytosol. Upon contact of CTLs with target cells, the lytic
granules are re-orientated and recruited to the immunological
synapse (IS), along with the microtubule-organizing center
(MTOC), the Golgi apparatus and mitochondria1, 2. At or near
the immunological synapse, lytic granules fuse with the cell
membrane and release perforins and granzymes to kill target
cells3.
CD8+ T cell contact with cognate antigen leads to intracellular
T cell receptor (TCR)-mediated signaling that, along with co-
stimulatory signals, orchestrates gene expression programs to
control the expansion and differentiation of CD8+ T cells to CTLs
in peripheral lymphoid organs. Upon primary stimulation and
the generation of effector cells, most of the activated CD8+ T cells
die, but a small number of cells survive and develop into memory
CD8+ T cells. According to surface expression and similar to CD4
+ T cells, memory CD8+ T cells are classiﬁed into central memory
CD8+ TCM cells and effector memory CD8+ TEM cells that differ
in their homing capacity and effector function4, 5. However, the
identiﬁcation of tissue-resident memory TRM cell subsets suggests
that a variety of other CD8+ memory T cells exist to ensure
optimal immunity against infection and cancer6.
One prominent signaling network that has an important
function in the generation and function of activated CD8+ T cells
and CTLs is the Ca++/calcineurin/NFAT network. Activation of
this network is initiated by the TCR-mediated release of Ca++
from endoplasmic stores, resulting in the multimerization of
Stromal interaction molecules (STIM) that contact pore-forming
ORAI proteins and activate Ca++ inﬂux from the extracellular
space through Ca++ release activated Ca++ channels (CRAC)7.
The rise of intracellular Ca++ leads to the rapid activation of the
Ser/Thr-speciﬁc phosphatase calcineurin that binds and depho-
sphorylates the highly phosphorylated cytosolic NFAT proteins,
and stimulates their nuclear import8.
The family of NFAT transcription factors consists of ﬁve
members that share a common DNA-binding domain of
approximately 300 amino acid residues. There are only a few
studies on NFAT transcription factors in CD8+ T cells. In one
study, a defective nuclear translocation of NFATc1 has been
described for NFATc1 in CD8+ T cells upon chronic infection9,
whereas in another study a predominant nuclear localization of
NFATc1 was reported for anergic CD8+ T cells10. The effect of
NFATc1 (NFAT2) ablation on CD8+ T cell physiology has been
reported11, but genome-wide assays on the effect of NFATc1 on
gene expression in CTLs have not.
Here we show that upon TCR stimulation, ablation of NFATc1
results in an impaired formation of F-actin rings around
the immunological synapse in CTLs, and poor recruitment of
lytic granules and mitochondria to the synapse. Genome-wide
transcriptome and chromatin immuno precipitation (ChIP)
assays show that NFATc1 controls genes (including Il2 and Ifng)
that orchestrate the activity of activated CD8+ T cells (aCD8+
T cells) and CTLs. Although NFATc1 and NFATc2 overlap in
their binding to most of these genes, in most cases NFATc1 has a
much stronger transcriptional effect than NFATc2 in aCD8+
T cells and CTLs. Upon activation, Nfatc1−/− aCD8+ T cells
reduce the metabolic switch from oxidative phosphorylation
(OXPHOS) to glycolysis, an effect that can be restored by IL-2.
Taken together our data demonstrate that NFATc1
controls transcription of genes that direct the cytotoxicity of
CD8+ T cells.
Results
NFATc1 for cytoskeleton reorganization in activated CTL.
NFATc1 ablation alters the shape of CTLs. When WT CTLs
adhere to a glass slide on which αCD3/CD28 have been attached
they spread out in a velvet-like lamellipodium. By contrast,
Nfatc1−/− CTLs form numerous spikes and ﬁlopodia-like
structures which differ conspicuously from the shape of WT
CTLs (Fig. 1a), and the area covered by Nfatc1−/− CTLs is
reduced, compared to WT CTLs (Fig. 1b).
The rapid formation of IS at the TCR is accompanied by the
depletion of cortical F-actin, the accumulation of MTOC, and the
recruitment of mitochondria and lytic granules12. When we
studied the formation of F-actin rings generated around the IS
upon activation by total internal reﬂection ﬂuorescence (TIRF)
microscopy, we detected radially symmetric F-actin rings for
WT cells whereas Nfatc1−/− CTLs generated no or smaller and
irregular rings (Fig. 1b–d).
The decrease of actin density in the center of IS is accompanied
by the appearance of MTOC (Fig. 1d, e) consisting of
microtubules and further cytosolic components13, including
attached mitochondria and lytic granules14. Using TIRF we did
not observe in Nfatc1−/− CTLs a marked delay in MTOC
accumulation (Fig. 1d). However, a defect was detected in the
assembly of mitochondria and lytic granules at the IS in living
cells using ﬂuorescence microscopy. Upon staining of WT and
Nfatc1−/− CTLs for mitochondria with MitoTracker® and lytic
granules with LysoTracker® followed by incubation of cells with
αCD3/CD28-coated beads we detected the recruitment of
mitochondria and cytotoxic granules to the IS in living WT
CTLs within 1-5 min. In Nfatc1−/− CTLs both types of organelles
did not, or slowly accumulate at the IS (Fig. 1f and Supplementary
Fig. 1). Staining of CTLs with Abs directed against granzyme B
revealed an accumulation of granzyme B-positive spots in the
cytosol of Nfatc1−/− and Nfatc1−/− +Nfatc2−/− but not in WT or
Nfatc2−/− cells, and in the supernatant of Nfatc1−/− CTLs a
reduction in granzyme B levels was detected (Supplementary
Fig. 2a, b).
NFATc1 affects CTL-mediated killing. The changes in mor-
phology of Nfatc1−/− CTLs suggest defects in their cytolytic
activity. To identify such defects at the cellular level, we investi-
gated ﬁrst the killing of MOPC 315 plasmacytoma cells expres-
sing a luciferase reporter gene by Nfatc1−/− aCD8+ T cells.
A marked decrease in cytolytic effector function of Nfatc1−/−
cells was observed reaching approximately 50% of that of WT
aCD8+ Ts, whereas only a slight difference was detected between
Nfatc2−/− and WT aCD8+ Ts (Fig. 2a). A decrease in killing
capacity was also observed for sorted CD62L−CD44+ CTLEM cells
(Supplementary Fig. 3a). WT and Nfatc1−/− CTLs generated from
CD8+ T cells of C57/BL6 mice by co-culture with irradiated Balb/
c splenocytes for 6 d and A20J tumor cells as targets (see Sup-
plementary Fig. 3b) revealed a 40% decrease in killing, compared
to WT CTLs. Those Nfatc1−/− CTLs showed also a reduction in
the surface expression of the degranulation marker CD107a
whose induction is correlated with the cytotoxicity of cells
(Fig. 2b). Moreover, they showed a reduction in the number of
cells producing IFNγ, IL-2 and TNF whereas the number of CTLs
expressing IL-17 and granzyme B was increased (Fig. 2c; Sup-
plementary Fig. 3c). No or subtile differences were detected
between WT and Nfatc1−/− CTLs regarding the surface expres-
sion of CD62L, CD44, CD25, FasL and CD69 (Supplementary
Fig. 3d).
Listeria monocytogenes infection induces a strong CD8+ T
cell response that combats infection15. To investigate the role
of NFATc1 in CTL responses against Listeria monocytogenes,
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Fig. 1 NFATc1 controls the re-organization of cytoskeleton and polarization of cytosolic organelles. a Spreading of WT and Nfatc1−/− (Nfatc1f/f x CD4-cre
mice) CTLs on αCD3/CD28-coated glass slides within 5 min. Scanning electron microscopy. LP, lamellipodium. b Quantiﬁcation of data of spreading
(above) and F-actin ring formation (below) of CTLs activated for 5 min (t-test, unpaired, p-value< 0.0001). Left; each dot/triangle corresponds to one cell.
Right; mean of three independent experiments. c Formation of F-actin rings in WT and Nfatc1−/− CTLs upon αCD3/CD28 activation within 5 min. TIRF
microscopy. d Appearance of MTOC-tubulin near the IS of CTLs upon activation for 5 min. TIRF microscopy. e Organization of F-actin and MTOC-tubulin in
CTLs upon activation for 20min. Confocal microscopy. For scale bar see d. f Repositioning of mitochondria and lytic granules to the IS in living WT but not
Nfatc1−/− CTLs. Left; analysis by confocal microscopy; overlay of bright ﬁeld and merged ﬂuorescence images of lysosomes (red) and mitochondria (green).
The dark dots correspond to beads coated with αCD3/CD28. Right; quantiﬁcation by epiﬂuorescence microscopy. The column presentation compiles the
data of more than 15 cells from 3 mice each
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we infected WT and Nfatc1f/f x CD4-cre mice with the transgenic
(tg) strain ΔActA Lm-Ova lacking protein ActA expression that
induces actin assembly16. Listeria monocytogenes bacteria were
detected in the livers of 8 of the 14 Nfatc1f/f x CD4-cre mice
infected with ΔActA Lm-Ova for 5 d whereas only two of the WT
mice showed signs of infection (Fig. 2d). Infected Nfatc1ﬂ/ﬂ x
CD4-cre mice showed an increase in number of CD62L+, CD44+
central and decrease of CD62L−, CD44+ effector memory cells,
and a reduced number of cells producing TNF and IL-2,
compared to WT mice (Fig. 2e, f; Supplementary Fig. 3e).
NFAT expression in aCD8+ T cells and CTLs. The effect of
NFATc1 on CTL activity led us to study NFAT expression in
CD8+ T cell cultures. To generate CTLs, splenic CD8+ T cells
were stimulated ﬁrst with plate-bound αCD3/CD28 for 3 d
(resulting in aCD8+ T cells), followed by incubation with IL-2 for
5–6 d. To mimic contacts with target cells, ﬁnally CTLs were
stimulated by TPA and Ionomycin (T + I) for 5 h (Fig. 3a). These
culture conditions approximate CD8+ T cell responses in vivo and
allowed us to generate large numbers of cells for molecular studies.
Stimulation of CD8+ T cells by αCD3/CD28 resulted in a
strong increase of NFATc1 expression within 1 d. At the RNA
level, this led to a moderate 3 fold increase in P1 promoter-
directed Nfatc1 and a decrease in both P2-directed Nfatc1 and
Nfatc2 transcripts (Fig. 3b, c). At the protein level, a strong
increase in short isoform NFATc1/αA was observed (see asterisks
in Fig. 3d). However, further incubation of aCD8+ Ts in IL-2
medium led to the disappearance of NFATc1/αA RNA and
protein (Fig. 3c, d). Stimulation of CD8+ T cells by αCD3/CD28
resulted in a slow increase in nuclear NFATc2 that further
increased upon incubation in IL-2 medium for 2-3 d and declined
afterward.
T + I re-stimulation resulted in an increase of nuclear NFATc2 in
CTL + cells (Fig. 3e).
CTL + cells rapidly re-gained the ability to synthesize NFATc1
proteins. However, several of the newly synthesized NFATc1
proteins were smaller than NFATc1/αA. Since incubation of
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Fig. 2 Defective killing activity of NFATc1-deﬁcient aCD8+ Ts and CTLs. a Defective killing of MOPC 315 plasmacytoma cells expressing a luciferase
indicator gene by aCD8+ Ts generated upon activation by αCD3/CD28 for 3 d in vitro. WT, Nfatc1−/− (Nfatc1f/f x CD4-cre mice) and Nfatc2−/− aCD8+ Ts
were incubated with MOPC target cells for 24 h. As controls, naive CD8+ T cells were incubated, and WT aCD8+ Ts were incubated without MOPC target
cells, and WT aCD8+ Ts were incubated without MOPC target cells. b Defective killing of A20J target cells by Nfatc1−/− CTLs. WT and Nfatc1−/− C57/B6
CTLs were generated by incubation with irradiated splenocytes from Balb/c mice for 6 d, followed incubation with A20J Balb/c tumor cells for 2 h (see
Supplementary Fig. 3b for details). Left, apoptosis induction of A20J cells is presented. Right, the degranulation of CTLs is shown. c Changes in number of
NFATc1-deﬁcient CTLs expressing various cytokines, granzyme B (Gzmb) or perforin (Prf1). Intracellular cytokine expression of CTLs was measured by
ﬂow cytometry upon stimulation by T + I for 6 h. Granzyme B and perforin expression was measured without T + I stimulation. d Defective clearance of
Listeria monocytogenes upon infection in mice bearing NFATc1-deﬁcient T cells. WT and Nfatc1f/f x CD4-cre mice were infected with 5 × 105 CFU ΔActA
Lm-Ova66 bacteria. 5 d later, the mice were sacriﬁced and Lm titers in livers were determined. e Distribution of splenic CTLs upon Lm infection of WT mice
and Nfatc1 f/f x CD4-cre mice. Control, uninfected mice. f Number of cytokine-producing CTLs upon Lm infection in Nfatc1f/f x CD4-cre mice. Data are
shown as means± SEM. Unpaired Student’s t-test was used for statistics
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NFATc1/αA with protein extracts of CTLs resulted in peptides of
the same size, they are most likely degradation products of
NFATc1/αA that often lost the α-peptide (see lane 12 in Fig. 3d,
and compare Supplementary Fig. 4a with Fig. 3d). As described
previously17, such cleavage was also detected for NFATc2
(Fig. 3e).
NFAT-mediated gene expression in aCD8+ T cells and CTLs.
To determine the transcriptional program controlled by NFATc1
in CD8+T cells, we performed transcriptome analysis of aCD8+
Ts and CTLs generated from splenic CD8+ T cells of WT and
Nfatc1f/f x CD4-cre mice that did not show any NFATc1
expression in their aCD8+ Ts and CTLs (Supplementary Fig. 4b).
For comparison, we also determined the transcriptome of
Nfatc2−/− mice by next generation sequencing (NGS). We
sequenced mRNAs from (i) activated CD8+Ts (aCD8+ Ts),
(ii) CTL− and (iii) CTL + cells.
In the three types of CD8+ T cells shown in Fig. 3a, 6000–6500
genes were expressed in more than 4 reads per kilobase per
million mapped reads (RPKMs). In the heat map, transcripts of
561 genes are listed (Fig. 4a) whose expression was found to be
changed 2 fold or more in at least one cell type. As expected from
the high levels of nuclear NFATc1 in aCD8 + T cells and CTLs,
we detected a 2.5-fold transcriptional alteration in 188 and 357
genes between WT and Nfatc1−/− aCD8 + T cells and CTLs
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respectively. Only 14 and 57 genes were changed in Nfatc2−/−
aCD8+ Ts and CTLs + . We observed only 6 genes that were
affected in both Nfatc1−/− and Nfatc2−/− aCD8+ Ts, whereas in
CTLs− the transcription of 13 and in CTLs + 26 genes were
changed (Fig. 4b). Among them are the Ifng, Il3, Batf3 and CD40l
genes, and the genes encoding the chemokines Ccl3, Ccl4
and Xcl1.
The stronger effect of NFATc1 on gene expression in aCD8+
Ts and CTLs + is also visualized in scatterplots of NFAT-
dependent genes. While ablating NFATc2 exerted a relative mild
effect, NFATc1 ablation resulted in much stronger changes in
gene expression in aCD8+ Ts and CTLs + (Fig. 4c). Functional
annotation of NFATc1-dependent genes in aCD8+ Ts and CTLs
+ revealed that a large proportion of deregulated genes encoding
enzymes in both cell types (Fig. 4d).
To identify the chromosomal sites and genes to which
NFATc1/A binds in CTLs + we performed ChIP seq assays. Since
ChIP-grade NFATc1 Abs are not available, we created a BAC tg
mouse line in which the biotin-ligase BirA from E. coli and
chimeric NFATc1/A-Bio proteins are co-expressed18 (Fig. 5a).
From those mice, CD8+ T cells were isolated, differentiated into
CTLs and stimulated with T + I for 5 h (to generate CTL + cells).
Cross-linked NFATc1/A-chromatin complexes could be isolated
with high speciﬁcity using streptavidin-coated magnetic beads
and, upon removal of cross-links and DNA isolation, subjected to
NGS of DNA.
Similar to the endogenous Nfatc1 gene, the BAC Nfatc1 tg was
induced upon induction of CTLs by T + I for 5 h (Fig. 5b). The
results of ChIP seq assays revealed 19 759 DNA peaks upon
annotation to the mm9 mouse genome. Motif analyses within
these short DNA stretches resulted in the typical TGGAAA (or—
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on the reversed strand—TTTCCA) NFAT ‘core’ binding motif
(Fig. 5c). Among the 357 genes whose RNA expression differed
more than 2.5-fold between WT and Nfatc1−/− CTL cells
stimulated by T + I for 5 h, 199 genes (56%) showed peaks for
NFATc1/A-Bio. Therefore, they correspond to direct NFATc1
targets. According to published data19, 187 of the 357 genes
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showed binding for NFATc2, and 161 genes showed binding for
both NFATc1 and NFATc2 (Fig. 5d).
The Ifng, Il2 and Il3 genes are prototypes of NFAT target
genes20–22. While NFATc1 and NFATc219 bind predominantly to
the Il2 promoter and to a site 2.3 kb upstream, both NFAT factors
bind to multiple sites around the Il3 and Ifng loci. NFATc1
ablation abolished RNA induction of all three genes in CTLs.
Although NFATc2 binds to almost the same sites as NFATc1
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within and around the Il3, Ifng and Il2 genes, NFATc2 ablation
resulted in very different effects on their expression. While
NFATc2 ablation did not affect Il2 induction, it reduced Ifng
induction to approximately 55% and inhibited almost completely
Il3 induction in CTLs (Fig. 5e).
NFATc1 ablation affects CD8+T cell differentiation. Nfatc1−/−
aCD8+ T cells show a decrease in proliferation compared to WT
and Nfatc2−/− cells. Using a low concentration of plate-bound
αCD3 (0.05 and 2 μg/ml αCD28) we detected a marked difference
in proliferation between WT, Nfatc1−/− and Nfatc2−/− aCD8+
T cells. In contrast, all three types of CTLs did not display any
difference in proliferation in medium containing high (100 U/ml)
or low concentrations of IL-2 (10 U/ml; Fig. 6a). Among the
numerous genes encoding cell cycle regulators, only the Cdkn1a
gene encoding the cell cycle inhibitor p21WAW/CIP1 was found as
NFATc1 target in aCD8+ T cells. In aCD8+ T cells, NFATc1
inactivation led to a decrease in Cdkn1a RNA levels to ~60%, and
NFATc1/A bound within and upstream from the Cdnk1a gene
(Fig. 6b, Supplementary Figs. 4c, d).
Several genes whose expression controls the differentiation to
effector and memory CTLs are direct NFAT targets. T-bet and
Eomesodermin (Eomes) are key transcription factors controlling
CD8+T cell differentiation6. In Nfatc1−/− CTLs + the RNA level
of the Tbx21 gene encoding T-bet corresponds to approximately
30% of the WT level, and a lower T-bet protein expression was
detected in Nfatc1−/− (and Nfatc2−/−) CTL + cells (Fig. 6c–e).
NFATc1 (and NFATc2) binds to two intronic sites and strongly
to one site 11 kb upstream of the Tbx21 gene (Fig. 6f). In contrast,
the Eomes gene is not bound by NFATc1, and its expression was
found to be strongly enhanced in Nfatc1−/− CTLs (Fig. 6c–e)
reﬂecting the reciprocal expression of both transcription
factors23. NFATc1 also binds to and controls in aCD8+ T cells
the Il12rb1 and Il12rb2 genes (Supplementary Fig. 5a) encoding
the IL-12 receptor that enhances Tbx21 expression via mTOR24.
In Nfatc1−/− aCD8+ Ts only one third of the Gzmb transcripts
were generated compared to WT aCD8+ T cells, and NFATc1
binds to several sites of the Gzmb gene (Supplementary Fig. 5b).
The transcript levels of Prf1 and Gzmb genes encoding the most
prominent perforins and granzymes in CD8+ T cells increases
10-fold from aCD8+ Ts to CTLs but NFATc1 ablation led
unaffected their expression in CTLs (Fig. 6c).
Among ‘fate markers’ for memory T cells, the Ccr7 and Il7r
genes are NFATc1 targets. NFATc1 ablation led to a 4-5-fold
decrease in Il7ra transcripts in CTL + cells encoding the IL-7
receptor α chain CD127, a marker for long-living memory
T cells25. NFATc1 binds also to the Itgae gene encoding the
integrin αE/CD103 that is highly expressed on tissue-resident
memory T cells, and NFATc1 ablation led to a decrease in Itgae
transcript levels in CTLs (Figs. 6c, g; Supplementary Fig. 6).
Furthermore, NFATc1 target genes are the Irf4 and Tcf7 genes
that control CTL activity and differentiation26, 27 (Fig. 6g;
Supplementary Fig. 6).
Among the genes encoding cytoskeleton proteins the Actb,
Tuba1b, Tubb5 and Vim genes are highly transcribed in aCD8+
T cells but only the level of Tubb5 and Vim transcripts decreased
to 61.5 and 40% in Nfatc1−/− aCD8+ Ts. In Nfatc1−/− CTLs, the
transcript levels of Actn1 and Plek genes were strongly impaired,
compared to WT cells, and both genes are bound by NFATc1
(Supplementary Fig. 7a, b).
NFATc1 controls the metabolism of CD8+ T cells. The tran-
script level of almost all genes controlling glycolysis28 is sig-
niﬁcantly lower in Nfatc1−/− than WT or Nfatc2−/− aCD8+
T cells (Fig. 7a; Supplementary Fig. 8). This observation
prompted us to study the role of NFATc1 in metabolism reg-
ulation of CD8+ T cells. Due to their high proliferation rate,
activated T cells have a high demand for energy and cellular
building blocks, as nucleotides and amino acids and, therefore,
switch their metabolism from OXPHOS to glycolysis29. In RT-
PCR assays we determined less than 30–35% of WT transcript
level for the Slc2a1, Slc2a3 and Hk2 genes encoding the glucose
transporters Glut1 and Glut3, respectively, and hexokinase 2
(Hk2), the enzyme responsible for the ﬁxation of glucose in cells
(Figs. 7a, b; Supplementary Fig. 8). Using the ﬂuorescent glucose
analog 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-
deoxy-D-glucose (2-NBDG) we observed a 70% reduction in
glucose uptake into Nfatc1−/− aCD8+ Ts, compared to WT,
whereas only a slight decrease was detected for Nfatc2−/− cells
(Fig. 7c). The decrease in glucose incorporation was accompanied
by a decrease in extracellular acidiﬁcation rate (ECAR) of
Nfatc1−/− aCD8+ Ts, as measured by extracellular ﬂux analysis.
For aCD8+ Ts generated with a low concentration of αCD3 (0.05
and 2 μg/ml αCD28) a 5-fold increase in glycolysis and glycolytic
capacity was observed, while cells stimulated with standard
concentrations (5 μg/ml αCD3, 2 μg/ml αCD28) displayed a three
fold increase in both parameters. However, Nfatc1−/− aCD8+ Ts
stimulated with either low or high concentrations of αCD3/CD28
exhibited lower glycolysis and glycolytic capacity of 40–60% of
WT level (Fig. 7d).
Contrary to the effect on glycolysis, NFATc1 ablation exerted
only a moderate effect on mitochondrial respiration. In mito
stress tests, the oxygen consumption rate (OCR) differed
only slightly between WT and Nfatc1−/− aCD8+ Ts, although
Nfatc1−/− aCD8+ Ts showed a tendency towards increased
maximal respiration, compared to WT cells (Fig. 7e), and the
RNA levels of genes encoding mitochondrial OXPHOS enzymes
were slightly enhanced (Supplementary Fig. 9a).
In part, the decrease in glucose incorporation of Nfatc1−/−
aCD8+ Ts could be restored by overexpressing a constitutive
nuclear (c.n.) version of NFATc1/αA. For this purpose we
analyzed aCD8+ T cells from c.n.Nfatc1/αA x Nfatc1f/f x dlck-cre
mice. Due to cre expression directed by the distal lck promoter30
these mice express c.n.NFATc1/αA upon removal of a ‘ﬂoxed’
STOP sequence from the Rosa26 locus31 in the absence of
endogenous NFATc1. Those cells revealed a moderate, but
reproducible increase in their glucose uptake, and in Il2 and Myc
RNA levels (Fig. 7f).
The effect of NFATc1 ablation on glycolysis led to the question
of whether NFATc1 exerts a direct effect on glycolytic genes.
However, in ChIP seq assays apart from the Hk2 and Gapdh
genes (Supplementary Fig. 10a) no further genes of the glycolysis
cascade showed distinct NFATc1 binding. One mediator of
the NFATc1 effect could be IL-2 whose expression is strongly
diminished in Nfatc1−/− T cells (Fig. 5e). IL-2 is known to activate
multiple metabolic and transcriptional programs in T cells,
mainly through the Ser/Thr kinase mTORC1, a prominent IL-2
target in T cells32. When we tested the effect of IL-2 in splenic
CD8+ T cells on 4E-BP1, a direct target of mTOR signals, we
observed a marked increase in TCR-mediated phosphorylation
that was inhibited by rapamycin. However, NFATc1 ablation was
without effect on 4E-BP1 phosphorylation (Supplementary
Fig. 9b). Nevertheless, adding 100 U/ml IL-2 to CD8+ T cell
cultures that were activated by αCD3/CD28 for 3 d revealed a
marked increase in glycolysis of NFATc1-deﬁcient cells (Fig. 7g).
This ﬁnding is supported by similar RNA levels of glycolytic
genes in WT and Nfatc1−/− CTLs that were cultured in IL-2-
containing medium for 6 d. Although we observed a drop in
Slc2a1 and Hk2 RNA levels, we observed a similar glucose uptake
and glycolysis of these cells (Supplementary Fig. 9c–f). Even upon
re-stimulation of CTL- cells by αCD3/CD28 for 16 h, no
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differences in glycolysis and glycolytic capacity were detected
between both types of cells (Supplementary Fig. 9f).
These ﬁndings do not exclude that NFATc1 affects also the
metabolism of CTLs. The strong NFATc1 binding to the Slc7a5
gene (Supplementary Fig. 10a) encoding a leucine transporter
that coordinates the metabolic reprogramming of CTLs33
suggests that in CTLs NFATc1 controls metabolic pathways
other than glycolysis.
While IL-2 enhanced the level of glycolysis of Nfatc1−/−
aCD8+ Ts to that of Nfatc2−/− cells, it did not completely rescue
glycolysis to the level of WT cells. This suggests that genes in
addition to Il2 that affect glycolysis might be controlled by
NFATs. Candidates are the Irf4 and Myc genes. Both control the
metabolic re-programming of T cells upon TCR stimulation26, 28
and their RNA levels were markedly diminished in Nfatc1−/−
aCD8+ Ts, and the Irf4 gene showed NFATc1 binding (Fig. 6g;
Supplementary Figs 6 and 10b).
Discussion
The results of our study show that NFATc1 controls the effector
function of CD8+ T cells at multiple levels. Nfatc1−/−
aCD8+ T cells exhibit a decrease in proliferation and metabolic
switch from OXPHOS to glycolysis, and—at the molecular
level—in a poor RNA expression of genes coding for numerous
glycolytic genes. This is mainly due to the missing IL-2 whose
expression is induced by NFATc1. The diminished expression of
Tbx21, encoding a key transcription factor of effector CD8+ Ts,
and of Gzmb gene are further molecular signs of defective func-
tion of Nfatc1−/− CD8+ T cells. Upon activation, Nfatc1−/− CTLs
exhibit an impaired depletion of apical F-actin and recruitment of
lytic granules and mitochondria to the IS, and in a strong
reduction in induction of numerous cytokine and chemokine
genes. These include, apart from the Il2 gene, the genes encoding
IFN-γ and IL-3, and the chemokine Ccl3, Ccl4, and Xcl1 genes
(Fig. 4). These defects culminate in the defective eradication of
infected and malignant cells.
In CTLs, NFATc1 and NFATc2 overlap in their binding to
almost all genes (and sites) but differ strongly in their tran-
scriptional activity (Figs 4 and 5). These data seem to contradict
published data on the role of NFATs, in particular of NFATc2
(NFAT1), in the exhaustion of CD8+ T cells19, an anergy-like
state of activated CD8+ T cells chronically infected with viruses.
However, they are not necessarily in conﬂict with a promoting
role of NFATs in CD8+ T cell exhaustion. NFATc1 and NFATc2
differ in their expression in activated lymphocytes. While short
immune receptor signals trigger the rapid translocation of both
factors into the nucleus, more persistent signals induce the
transcription of Nfatc1 gene leading to the massive synthesis of
NFATc1/αA within a few hours (Fig. 3d). Although within several
days the levels of NFATc2 also increase by persistent TCR signals
(Fig. 3e), signals other than TCR triggering result in the further
increase of NFATc2 in peripheral T cells34. These and further
data led us to conclude that the Nfatc1 gene codes for (at least)
two factors which differ remarkably in their transcriptional
properties35. In our view (i) NFATc1/αA which is highly
expressed in activated T cells (Fig. 3d) supports ‘immunity’, i.e.
the effector function of lymphocytes, including glycolysis,
whereas (ii) NFATc1/ßC (and other longer NFATc1 isoforms)
which is mainly expressed in resting T cells, supports the
induction of ‘tolerance’ and ‘exhaustion’ of lymphocytes35.
The latter shares peculiarities with NFATc2, such as two
SUMOylation sites within the C-terminal domain that is missing
in NFATc1/αA, and SUMOylation converts NFATc1/ßC to a
suppressor of IL-2 induction36.
In a study on the ablation of NFATc1 (NFAT2) in murine
CD8+ T cells, Pachulec et al.11 described an increase in the per-
centage of CD8+CD44highCD122+ cells in thymus, spleen and
LNs of unchallenged Nfatc1f/f x CD4-cre mice which the authors
classiﬁed as innate-like CD8+ T cells with characteristics of
conventional memory CD8+ T cells. In our Listeria infection
assays, we observed a slight increase in the number of Nfatc1−/−
TCM, compared to WT cells, and a decrease of Nfatc1−/− TEM
cells (Fig. 2e). The latter showed a decrease in their cytotoxicity
(Supplementary Fig. 3a), similar to the ﬁndings published by
Pachulec et al.11 for Nfatc1−/− CD8+T cells.
We focused our attention on the molecular events controlled
by NFATc1 (and NFATc2) during the activation and differ-
entiation of CD8+ T cells to CTLs in vitro generated mostly from
Nfatc1f/f x CD4-cre mice as well. Those mice showed a normal
development of peripheral CD4+/CD8+ T cells37. Several of our
data were also conﬁrmed by using Nfatc1f/f x dlck-cre mice in
parallel, in which the Nfatc1 gene was inactivated in peripheral
T cells, i.e. after thymic selection30. Taken together, our NGS and
ChIP seq data on the genome-wide gene control by NFATc1 in
CD8+ T cells conﬁrm and extend the data by Pachulec et al.11 on
the NFATc1-mediated control of IFNγ production in CD8+
T cells.
NFATc1 binds to numerous genes controlling the activity
and fate of CD8+ T cells, but several physiological events of
CD8+ T cells are also indirectly controlled by NFATc1. One
example is the metabolic switch from OXPHOS to glycolysis
during T cell activation, others might be the diminished
proliferation (Fig. 6a) and enhanced apoptosis of Nfatc1−/−
lymphocytes38. In Nfatc1−/− CD8+ T cells, the expression of
numerous genes encoding glycolytic enzymes are impaired, and
glycolysis is decreased to less than 50% of normal level in
WT cells. Adding IL-2 to aCD3/CD28-stimulated Nfatc1−/−
CD8+ T cells restored the defect to a large extent. In line with
published studies39–41 this implies that in addition to TCR signals
IL-2 supports the metabolic switch from OXPHOS to glycolysis
during primary T cell activation.
In ChIP seq assays both NFATc1 and NFATc2 were found to
bind at and near the promoter of the ll2 gene (Fig. 5e). However,
NFATc2 ablation did not-or very mildly-affect Il2 expression,
whereas NFATc1 ablation strongly impaired Il2 induction in both
aCD8+ Ts and CTLs + . It is currently unclear why NFATc1—and
not NFATc2—ablation exerts such a deleterious effect on Il2
transcription. One explanation might be the high concentrations
of NFATc1 in aCD8+ T and CTL + cells upon TCR stimulation
(Fig. 3d). It is known that the Il2 gene needs a certain threshold
level for NFATs to be transcribed42, 43 which might be reached by
NFATc1, but not NFATc2 expression. In contrast to this all-or-
none expression of the Il2 gene, the transcription of Ifng and Il3
genes seems to follow a gradual way that is affected by either
NFATc1 or NFATc2 ablation (Fig. 5e).
In addition to IL-2, the diminished expression of other factors,
such as of IRF4 and c-Myc, might also contribute to the impaired
metabolic switch to glycolysis in Nfatc1−/− aCD8+ Ts. The
TCR-mediated expression of c-Myc is enhanced by IL-2 signals44,
and—similar to Irf4—c-Myc was shown to bind to and to
enhance the expression of numerous glycolytic genes28. A further
candidate is the NFAT target gene Pdcd1 encoding the repressor
PD-1 that was shown to affect glycolysis45. In a recent study high
concentrations of intracellular L-arginine were reported to sup-
press glycolysis and to generate central memory-like T cells46.
Numerous cytokine and chemokine genes are direct NFATc1
targets, and by regulating those genes NFATc1 seems to control
the mobility and motility of CTLs and, thereby, their cytotoxicity.
It is unknown whether such NFATc1-dependent key molecules
control also the cytoskeleton re-organization and recruitment of
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mitochondria and lytic granules to the IS. The interplay between
mitochondria and Orai1 channels at the IS is highly relevant for
the generation of local (at the IS) and global Ca2+ signals (in the
cytosol and in the nucleus). Mitochondria take up Ca2+ and
reduce local Ca2+ domains at the IS, which in turn inhibit Ca2+
dependent inactivation of Orai1 channels47, 48. Thus, mitochon-
dria control local and global Ca2+ signals following TCR induced
Ca2+ entry by Orai1 channels. By controlling Ca2+ signals,
mitochondria regulate NFAT translocation into the nucleus in
CD4+ lymphocytes48.
While we did not detect defects in the expression of numerous
formin genes that orchestrate the formation of cytoskeleton49,
in CTLs a strong reduction was observed in the expression of
NFATc1-target genes Actn1 and Plek (Supplementary Fig. 6). The
expression of Actn1 gene encoding α-actinin 1 contributes to
T cell activation by forming multiprotein complexes with Lck and
Rack1 that couple actin skeleton with TCR triggering, and it was
shown to participate in T cell migration50, 51.
Taken together, our study revealed numerous novel NFATc1
targets in cytotoxic T cells. The detailed knowledge of their
NFAT-mediated control will help to interfere with the molecular
mechanisms that control the activity of cytotoxic T cells to
eradicate infected and malignant cells.
Methods
Mice and T cell activation. All mice used in the experiments were 8-12 weeks old,
at C57/B6 background and sex- and age-matched. The T cell-speciﬁc CD4-cre
mice have been described52. Two Nfatc1f/f mouse lines (also designated as Nfat2/f
mice19, 37, 53) and conventional Nfatc2−/− mice54 were used. The c.n.Nfatc1/αA x
Nfatc1f/f x dlck-cre mice express a constitutively active version of NFATc1/αA from
the Rosa26 locus upon removal of a ‘ﬂoxed’ STOP sequence31 in peripheral T cells.
Animal experiments were performed according to project licenses (55.2–2531.01-
53/10B and -76/14), which are approved by the Regierung von Unterfranken,
Würzburg. For CD8+ T cell isolation, the mouse CD8 (Ly2) microbeads kit
#130-049-401 kit (Miltenyi Biotech) was used according to the manufacturer’s
protocol. After puriﬁcation, the purity of CD8+ T cells was checked by ﬂow
cytometry. Cells were suspended in X-vivo medium to a ﬁnal concentration of
2 × 106/ml. For αCD3/CD28 stimulation, if not stated otherwise 5 μg CD3ε (clone
37.51) and 2 μg CD28 (clone 145-2C11) (both BD Pharmingen) were diluted in
1 ml PBS which was used to coat multi well plates. T cells were also stimulated with
10 ng/ml TPA and 0.5 μM ionomycin (normally for 5 h). To generate CTLs, CD8+
T cells were either treated by αCD3/CD28 for (2-) 3 d followed by incubation for
(5-) 6 d in medium containing 100 U/ml hIL-2. In some assays, CD8+ T cells were
co-cultured for 6 d with splenocytes from a Balb/c mouse that were irradiated
(by 30 Gy, 5′, 16 kV).
Cytotoxicity assays. In the ﬁrst assay (Fig. 2a), the mineral oil induced murine
MOPC-315.BMP2.FUGLW55 plasmacytoma cell line (H2b) expressing eGFP and
luciferase was used as target cell line for killing assays. This cell line originates from
an allogeneic donor and, therefore, allo-reactive B6 CTLs recognizing the MHC
mismatch induce target cell death. To measure luciferase during co-culture with B6
CD8+ T cells, cells were re-suspended and aliquots were transferred into 1.5 ml
Eppendorf tubes. After centrifugation, the cell pellet was washed once with PBS
and ﬁnally resuspended in 100 μl harvesting buffer to lyse cell membranes. After
centrifugation, 50 μl of supernatant was transferred into a white, non-transparent
96-well plate. The LUMIstar Omega was primed with 1 ml of ready-to-use luciferin
solution before luciferase-activity measurement was performed. 50 μl of luciferin
solution per well were automatically added to the sample and measurement was
performed.
In the second assay (Fig. 2b) 104 cells A20J cells labeled with CFSE were
cultivated in 100 μl X-vivo medium with 105 CTLs at 37° for 4 h, followed by
staining with Abs for CD8a-biotin and Streptavidin-APC and ﬂow cytometry. Prior
analysis, cells were also stained by PI to distinguish living A20J target cells (CFSE+,
PI−) from dead cells (CFSE+, PI+).
Generation of Nfatc1/A-Bio BAC tg mice. Nfatc1/A-Bio BAC constructs were
generated by insertion of a C-terminal tag sequence for in vivo biotinylation56 into
the BAC RP23-361H16 containing the murine Nfatc1 gene (mm9 chr.18,
80,779,051–80,993,617, 214 kb) in front of the stop codon of exon 9. In a ﬁrst step a
targeting vector was generated with 5′ (1 kb) and 3′ (1 kb) homology regions
ﬂanking the tag sequence. The homology arms were generated by PCR using the
primers E9BoxA_AscI1kb_ubiofwd: 5′-TAGGCGCGCCTCTGAAATCCCCAGC
AGAAAT-3′, E9BoxA_Ex9-bio_transrev: 5′-TTGGTAAAAACCTCCTCTCAG
CTC-3′ for the 5′ and E9BoxB_bio-down_transfwd: 5′-TCAAACGCCGGAGGCT
CGTGAGCAGCCCCCCGAGGCTATAAG-3′, E9BoxB_NotI1kb_dbiorev: 5′-TAG
CGGCCGCCTGATAAGACAATTGGTTTCA-3′ for the 3′ region. The center tag
sequence was ampliﬁed with the primer pair Ex9bio_fwd: 5′-gagctgagaggaggtttt
tacCAATTGGGCGGTGGAGGTCTG-3′, E9BoxB_NotI1kb_dbiorev: 5′-TAGCG
GCCGCCTGATAAGACAATTGGTTTCA-3′. In a combined PCR using the
ampliﬁed fragments a fusion product was generated and cloned as an AscI and
NotI fragment into the shuttle vector pLD53.RecA57. After RecA mediated
recombination BAC DNA was tested for insertion of the tag sequence by two PCR
reactions with the primer pairs Ex9BoxAupst: 5′-ACCACACGAGGAAAGAA
ACG-3′, Ex9BioRev.: 5′-TCTTCTGCGAGTCGAGGATT-3′ (1235 bp) and
Ex9BioFwd: AATCCTCGACTCGCAGAAGA, Ex9BoxBdwn: 5′-ACAGACAGTT
GCTGCCCTTT-3′ (1143 bp) and by sequencing. NruI linearized BAC DNA
was microinjected into blastocysts. Mouse biopsies were tested by PCR for BAC
integration with the primers geEx9-bio-for: 5′-GTTTTTACCAATTGGGCGGT
GGA-3′, geEx9-bio-rev: 5′-CTCCATCTTCTGCGAGTCGAGGA-3′ (209 bp). The
5′-end of integrated BAC DNA was detected with the primer pair 5’BAC(T7)for:
5′-GGTCCATCCTTTTGTCTCA-3′ and 3′e3.6(T7)rev: 5′-CGAGCTTGACATT
GTAGGA-3′ (512 bp) and the 3′-end with the primers 5′e3.6(SP6)for: 5′-CGT
CGACATTTAGGTGACA-3′ and 3′BAC (SP6)rev: 5′-CCATCGTTCCCTGAC
TCA-3′ (439 bp).
Bio-ChIP analysis of NFATc1/A binding. CD8+ T cells were isolated from spleen
of Nfatc1/A-Bio+/− x Rosa26BirA+/− or Rosa26BirA+/− mice. After a primary
stimulation with plate-bound αCD3 (5 ng/ml) and αCD28 (10 ng/ml) for 48 h,
cells were harvested and cultivated for additional 3 d with medium containing
100 ng/ml hIL-2. Re-stimulation was performed by addition of TPA (5 ng/ml) and
Ionomycin (0,5 µM) for 5 h. Chromatin from 1 × 107 ﬁxed CTLs was prepared
using a lysis buffer containing 1% SDS and sonicated by a Vibra-Cell VCX 130
(Sonics, CT, USA) for 16′ before precipitation of chromatin by streptavidin beads
(M-280, #11205D, Thermo Fisher Scientiﬁc, MA, USA), essentially as described58.
The precipitated genomic DNA was controlled for fragment size by the Agilent
Bioanalyzer using a High Sensitivity DNA Chip according to the manufacturer’s
instruction (Agilent Technologies, CA, USA) and quantiﬁed by a Qubit 2.0 ﬂuo-
rometer using a ds DNA HS assay kit (Thermo Fisher Scientiﬁc, USA, Q32851).
7 ng of precipitated genomic DNA from Nfatc1/A-Bio+/− and Rosa26BirA+/− cells
was used for library preparation (NEBNext Ultra DNA Library Prep Kit for Illu-
mina, NEB) according to manufacturer’s instructions. The quantity of ﬁnal library
was assessed by Qubit 2.0 ﬂuorometer using a dsDNA HS assay kit, and the average
size was determined by Agilent’s Bioanalyzer on a high sensitivity DNA Chip.
Sequencing of the ﬁnal libraries was carried out as a 50 bp single read run on an
Illumina HiSeqTM2500 (Illumina, San Diego, USA) by the Institute of Molecular
Genetics (JGU, Mainz, Germany) using a TruSeq Rapid SBS Kit v2 and a HiSeq
Rapid Flow Cell v2. RTAVersion 1.18.64 was employed for cluster identiﬁcation.
Analysis was performed on usegalaxy.org59. 50 bp sequence reads that passed the
Illumina quality ﬁltering were aligned to the mouse genome assembly version of
July 2007 (NCB I37/mm9), using the Map with Bowtie for Illumina 1.1.2. Results
were visualized with the “Integrative Genomics Viewer” IGV version 2.3.8160. We
used the MACS program (Galaxy Version 1.0.1)61 with default parameters, a
genome size of 2,700,000,000 bp (mm9) and the reads from Rosa26BirA+/− IP as
control sample to identify peaks that were ﬁltered for P values of< 10−5. A P-value
of< 10−12 was used for comparison to NFATc2 binding19. Motif discovery was
performed with “Discriminative Regular Expression Motif Elicitation” (DREME)
version 4.11.262. Genes nearby 100 kb to annotated peaks were identiﬁed with
GREAT version 3.0.063.
Infections with Listeria monocytogenes. For Listeria infections in vivo, an atte-
nuated Listeria strain Lm-Ova ΔActA was used. The strain is defective in the
expression of the ActA protein that mediates normally direct cell-to-cell trans-
mission of replicated bacteria, and thereby increases virulence up to 1000 fold25.
5 × 105 colony forming units (CFU) from a cryo-conserved vial stock were
suspended in 200 μl PBS and injected i.p. into either WT or Nfatc1f/f x CD4-cre
mice. Mice were monitored daily, until they were sacriﬁced at d 5 post-infection.
Livers were gently meshed in PBS containing 0.1% TritonX-100 to destroy cellular
membranes. Serial 1:10 dilutions were made in PBS and 100 μl each were plated out
on agar plates selective for Listeria, and incubated at 37 °C for 2 d.
Immunoblotting and PCR assays. Immune blots were performed with whole
protein extracts on PAGE-SDS gels followed by detection of NFATc1 using 7A6
mAb #556602, or for NFATc2 mAb #5062574 (both BD Pharmingen). For
detecting NFATc1/α, a pAb raised against the NFATc1α-peptide Ab #IG-457
(ImmunoGlobe) was used. As loading control, ﬁlters were stained by Ponceau Red
(PR in Fig. 7f) and/or re-probed with the mAb #ab8227 speciﬁc for β-actin
(Abcam). Signals were developed using a chemiluminescence detection system
(Thermo Fisher Scientiﬁc).
For RT-PCR assays, RNA was isolated from washed and deep-frozen
lymphocytes using a standard TRIzol/isopropanol protocol. cDNAs were
synthesized using the iScript cDNA synthesis kit according to the manufacturer’s
instructions (Bio-Rad). Real-time PCR assays were performed using the SYBR
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green master mix (Applied Biosystem) using the primers presented in
Supplementary Table 1, and as described previously64.
Flow cytometry. T cells were washed once in cold PBS containing 0.1% BSA
(FACS buffer) before blocking with anti-FcγRII/FcγRIII (2.4G2, BD Pharmingen,
San Diego, CA). Stainings were performed on ice using conjugated mAbs
(eBioscience, San Diego, CA, if not stated otherwise), diluted 1:300 (1:200 for
intracellular cytokines) in FACS buffer followed by incubation for 20 min. After
washing with FACS buffer, cells were analyzed on a FACS Canto II (BD) and
FlowJo software (Tree star, Ashland, OR). The following Abs were used: CD8-FITC
(#11-0081-82), IL-2-APC (#17-7021-81), IFNγ-APC (#17-7311-82), CD62L-PE
(#12-0621-81), CD44-APC (#17-0441-81), Perforin-APC (#17-9392-80),
Granzyme B-PE (#12-8898-80). Abs against TNF-PE (#130-092-245), T-bet-PE
(#130-098-653) and IL-17-PE (#130-094-296) were from Miltenyi Biotec. For
intracellular staining, the ﬁxation and permeabilization kit (Plus Brefeldin A;
eBioscience, Cat. no. 88-8823-88) was used according to manufacturer’s
recommendation.
RNA seq assays. RNA from deep-frozen CD8+ T cells was extracted using Trizol.
Quantity of total RNA was assessed with the Qubit 2.0 and quality was checked
using a RNA 6000 Nano chip on Agilent's bioanalyzer. Sequencing libraries were
prepared from 600 ng total RNA using a NEBnext ultra RNA library prep kit
following the manufacturer’s instruction. The resulting barcoded cDNA libraries
were sequenced on an Illumina HiSeq 2500 platform for 50 nucleotides (single
end).
Imaging of cytoskeleton dynamics in CTLs. CTLs in warm RPMI/0.5% BSA
medium were activated on glass bottom chamber slides (µ-slides, Ibidi, Germany)
coated with αCD3/CD28 for the indicated time points. Co-stimulation was
immediately stopped by covering cells with a pre-warmed ﬁxation solution of 4%
formaldehyde and 0.05% glutaraldehyde in PBS for 10 min at 37°. Samples were
rinsed in PBS, permeabilized with 0.1% Triton X-100 for 5 min, treated with
50 mM NH4Cl for 10 min and blocked with 5% BSA. For visualization of ﬁla-
mentous F-actin cells were stained with phalloidin 488 (Actin-stain, Cytoskeleton)
and for MTOC reorientation with an anti-β-tubulin primary Ab (clone 9F3,
Cell Signaling) overnight at 4° followed by incubation with anti-rabbit-Alexa
568 secondary Ab (Invitrogen) for 45 min at RT and a ﬁnal step with DAPI for
nuclear staining. Preparations were stored in PBS for total reﬂection (TIRF)
microscopy and data were obtained by using a Leica AM TIRF system with
software AF 6000 LX, equipped with a 100x oil objective (HCX PL APO, NA 1.47)
and laser lines 488 and 561 nm. For confocal laser scanning microscopy (CLSM)
samples were covered with mounting medium (Ibidi). Images were acquired on
a Zeiss LSM 780, provided with 40x and 63x oil objectives (Plan-Apochromat,
NA 1.4) and laser excitation at 405, 488 and 561 nm and processed with software
ZEN 2012.
To quantify the size of F-actin depletion zone imaged by TIRF microscopy and
the increase in cellular spreading taken by CLSM on Ab-coated surfaces, cell area
was calculated after setting a manual threshold and measured in square micrometer
using the software platform Fiji65. For morphological examination under a ﬁeld
scanning electron microscope (SEM), CTLs were co-stimulated using 12 mm glass
slices in a 24-well plate, ﬁxed in pre-warmed 6.25% glutaraldehyde in 50 mM
phosphate buffer (pH 7.2) for 15 min at RT and subsequently overnight at 4 °C.
After three washing steps in PBS, samples were prepared by stepwise dehydration
in acetone, then critical point dried, sputtered with gold/palladium and imaged on
a JSM 7500 F (Jeol).
Imaging of recruitment of lytic granules and mitochondria. C57/B6 CD8+
T cells were puriﬁed and stimulated with irradiated BALB/c splenocytes as
described above. On d 5 after isolation, CTLs were sorted on a BD FACSAria
TMIII (70 µm nozzle, gating on FSC and SSC, cooled reservoir) to remove dead
cells and debris. CTLs were cultured overnight in X-vivo medium, loaded with
either 400 nM LysoTracker Green DND-26 and 100 nM MitoTracker Deep Red
FM or 400 nM Lysotracker Red DND-99 and 100 nM MitoTracker Green FM for
30 min at 37 °C, washed and transferred into a black clear-bottom imaging
microplate (Greiner 781096, 384 wells) in X-vivo medium containing either
400 nM LysoTracker Green DND-26 or 400nM LysoTracker Red DND-99
(1.3 × 105 CTL/well). Shortly before the start, 2 × 104 Dynabeads (Mouse T-
Activator CD3/CD28 beads; Life Technologies, 11456D) were added to each well.
Time-lapse imaging was performed on a Zeiss AxioObserver at 37 °C and 5% CO2
with a Fluar 20 × /0.75 objective, using transmitted light and epiﬂuorescence with
ﬁlter set 38 HE (Ex 470/40, Em 525/50) and a custom ﬁlter set (Ex 620/60, Em 700/
75). Background ﬂuorescence was subtracted, and the polarization of mitochondria
and lysosomes was quantiﬁed (assuming stable polarization when the ﬂuorescence
signal was close to the contact zone for more than 3 images (or 60 s)). For the
intensity proﬁles shown in Supplementary Fig. 1c, cells in stable contact with beads
for at least 10 frames (200 s) were analyzed if cell location was plane to the con-
tacting bead (the cell did not lie above or below the bead), no labeled organelles
were located above or below the bead and the cell diameter was larger than 5 µm in
order to faithfully localize the proximal and distal part of the cell. The selected cells
at the chosen time points were analyzed with Fiji ImageJ 2.0 using the “Line Tool”
(for round or elongated cell morphology) or the “Segmented Line Tool” (for cells
with non-symmetric morphology). A line was drawn from the contacting bead
towards the center of the IS and further along the midline of the cell body to the
rear of the cell and intensity values were measured along this line.
Metabolic assays. In extracellular ﬂux assays, ECAR of CD8+ T cells was mea-
sured with a XF96 analyzer (Seahorse Bioscience). 4 × 105 freshly prepared CD8+
T cells from WT, Nfatc1f/f x CD4-cre and Nfatc2−/− mice were maintained over-
night without stimulation or stimulated by αCD3/CD28. In parallel, the same
number of CTL- cells were stimulated for a further day by αCD3/CD8. Upon
counting, the cells were seeded in a plate pre-coated with poly-D-lysine (Sigma; 50
μg/ml) in XF Seahorse medium with glutamine alone. Then, 10 mM glucose was
injected, followed by 1 μM oligomycin and 20 mM 2-deoxyglucose. Mito stress test
assays for the determination of oxygen consumption rate (OCR) were performed in
a similar way according the manufacturers protocol (Seahorse Bioscience). 2-
NBDG (Cayman Chemical) assays were performed by incubation of cells with
50 μM 2-NBDG for 1 h at 37 °C followed by ﬂow cytometry.
Statistical analysis. Statistical analyses were performed using GraphPad (Prism)
software, version 6.0. Data presented as mean and error bars in ﬁgures represent±
SEM. Unpaired t-tests were performed to evaluate the statistical signiﬁcance of
the data set. Statistical signiﬁcances were calculated and indicated (***p< 0.001,
**p< 0.005 and *p < 0.05).
Data availability. Sequence data that support this study have been deposited in
NCBI’s Gene Expression Omnibus and are accessible through GEO Series acces-
sion number GSE98726. For analysis of NFATc2 binding, data from GSE64409
were used. All other data supporting the ﬁndings of this study are available with the
article, and can also be obtained from the authors.
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